Molinsky, R. L., Shah, A., Yuzefpolskaya, M., Yu, B., Misialek, J. R., Bohn, B., Vock, D., MacLehose, R., Borlaug, B. A., Colombo, P. C., Ndumele, C. E., Ishigami, J., Matsushita, K., Lutsey, P. L., & Demmer, R. T. (2025). Infection‐Related Hospitalization and Incident Heart Failure: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033877

AlShammari, A., Magdits, M., Majdalani, R., Devarajan, S., Hughes, A., McCann, L., Ionescu, N., & Raiszadeh, F. (2025). Heart Failure and Worsening Renal Function: Prevalence, Risk Factors, and Impact on Hospital Readmissions in an Urban Minority Population. Journal of Clinical Medicine, 14(3), 877. https://doi.org/10.3390/jcm14030877

Zhalbinova, M. R., Rakhimova, S. E., Kozhamkulov, U. A., Akilzhanov, K. R., Shaimardanov, N. K., Akilzhanova, G. A., Lee, J. H., Pya, Y. V., Bekbossynova, M. S., & Akilzhanova, A. R. (2024). The Impact of Genetic Polymorphism on Complication Development in Heart Failure Patients. Journal of Clinical Medicine, 14(1), 35. https://doi.org/10.3390/jcm14010035

Nemeh, C., Schmoke, N., Patten, W., Clark, E., Wu, Y. S., Wang, P., Kurlansky, P., Middlesworth, W., Cheung, E. W., & Rosenzweig, E. B. (2024). Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single‐institutional experience of outcomes. Pulmonary Circulation, 14(4). Portico. https://doi.org/10.1002/pul2.12442

HAJDUCZOK, A. G., DONALD, E. M., MANING, J., YOUMANS, Q., & REZA, N. (2024). Can’t Rain on Our Parade: Highlights from the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2024. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.10.001

Kwan, M. L., Pimentel, N., Izano, M., Iribarren, C., Rana, J. S., Nguyen-Huynh, M., Cheng, R., Laurent, C. A., Lee, V. S., Roh, J. M., Rillamas-Sun, E., Hershman, D. L., Kushi, L. H., Greenlee, H., & Neugebauer, R. (2024). Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLOS ONE, 19(9), e0310531. https://doi.org/10.1371/journal.pone.0310531

Martinez‐Morata, I., Domingo‐Relloso, A., Zhang, Y., Fretts, A. M., Pichler, G., Garcia Pinilla, J. M., Umans, J. G., Cole, S. A., Sun, Y., Shimbo, D., Navas‐Acien, A., & Devereux, R. B. (2024). Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study. Journal of the American Heart Association, 13(17). https://doi.org/10.1161/jaha.123.033772

Feng, I., Singh, S., Kobsa, S. S., Zhao, Y., Kurlansky, P. A., Zhang, A., Vaynrub, A. J., Fried, J. A., & Takeda, K. (2024). Feasibility of veno-arterial extracorporeal life support in awake patients with cardiogenic shock. Interdisciplinary CardioVascular and Thoracic Surgery, 39(2). https://doi.org/10.1093/icvts/ivae148

Krishnan, A. V., Freniere, V., Sahni, R., Vargas Chaves, D. P., Krishnan, S. S., Savva, D., & Krishnan, U. S. (2024). Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants. Children, 11(6), 703. https://doi.org/10.3390/children11060703

Kleet, A. C., Regan, M., Siceloff, B. A., Alvarez, C., & Farr, M. (2024). Psychosocial readiness assessment for heart transplant candidates. Heart & Lung, 67, 19–25. https://doi.org/10.1016/j.hrtlng.2024.04.013

Anand, T. V., Bu, F., Schuemie, M. J., Suchard, M. A., & Hripcsak, G. (2024). Comparative safety and effectiveness of angiotensin converting enzyme inhibitors and thiazides and thiazide‐like diuretics under strict monotherapy. The Journal of Clinical Hypertension, 26(4), 425–430. Portico. https://doi.org/10.1111/jch.14793

GOYAL, P., DIDOMENICO, R. J., PRESSLER, S. J., IBEH, C., WHITE-WILLIAMS, C., ALLEN, L. A., GORODESKI, E. Z., Albert, N., Fudim, M., Lekavich, C., Watson, K., Gulati, S., Kalogeropoulos, A., & Lewsey, S. (2024). Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. Journal of Cardiac Failure, 30(3), 488–504. https://doi.org/10.1016/j.cardfail.2024.01.003

Driggin, E., & DeFilippis, E. M. (2024). You Are Where You Eat: The Local Environment and Risk of Heart Failure. Circulation: Heart Failure, 17(3). https://doi.org/10.1161/circheartfailure.124.011468

Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., Chen, Y., Thompson, J. L. P., Homma, S., & Lip, G. Y. H. (2024). Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial. Internal and Emergency Medicine, 19(4), 931–939. https://doi.org/10.1007/s11739-024-03544-4

Uppal, D., DeFilippis, E. M., Dietz, J., Baran, D., Estep, J. D., Velez, M., Rivera, N. T., & Snipelisky, D. (2024). National shortage of home intravenous inotrope agents: The “inotrope pandemic” continues. JHLT Open, 3, 100023. https://doi.org/10.1016/j.jhlto.2023.100023

Prasad, P., & Prasad, M. (2024). In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 91(2), 82.2-83. https://doi.org/10.3949/ccjm.91c.02002

Kanwar, M. K., Billia, F., Randhawa, V., Cowger, J. A., Barnett, C. M., Chih, S., Ensminger, S., Hernandez-Montfort, J., Sinha, S. S., Vorovich, E., Proudfoot, A., Lim, H. S., Blumer, V., Jennings, D. L., Garan, A. R., Renedo, M. F., Hanff, T. C., Baran, D. A., Overgaard, C., … Saeed, D. (2024). Heart failure related cardiogenic shock: An ISHLT consensus conference content summary. The Journal of Heart and Lung Transplantation, 43(2), 189–203. https://doi.org/10.1016/j.healun.2023.09.014

Corica, B., Romiti, G. F., Simoni, A. H., Mei, D. A., Bucci, T., Thompson, J. L. P., Qian, M., Homma, S., Proietti, M., & Lip, G. Y. H. (2024). Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post‐hoc analysis from the WARCEF trial. European Journal of Clinical Investigation, 54(5). Portico. https://doi.org/10.1111/eci.14152

Azad, H., Wen, T., Krenitsky, N., Bello, N., Booker, W. A., Purisch, S., D’Alton, M., & Friedman, A. M. (2024). 746 Peripartum cardiomyopathy delivery hospitalization and postpartum readmission trends, risk factors, and outcomes. American Journal of Obstetrics and Gynecology, 230(1), S397–S398. https://doi.org/10.1016/j.ajog.2023.11.771

Calì, F., & Pinsino, A. (2024). Heart Failure Guideline-Directed Medical Therapy in End-Stage Kidney Disease: From PARADIGM-HF to Clinical Practice. Kidney International Reports, 9(1), 13–15. https://doi.org/10.1016/j.ekir.2023.11.015

Mukhopadhyay, A., Blecker, S., Li, X., Kronish, I. M., Chunara, R., Zheng, Y., Lawrence, S., Dodson, J. A., Kozloff, S., & Adhikari, S. (2023). Neighborhood-Level Socioeconomic Status and Prescription Fill Patterns Among Patients With Heart Failure. JAMA Network Open, 6(12), e2347519. https://doi.org/10.1001/jamanetworkopen.2023.47519

Michael, M., Taylor, B., Dilawri, A., & Pinkos, K. (2023). 1503: EVALUATION OF ANGIOTENSIN II FOR VASOPLEGIC SHOCK AFTER CARDIAC SURGERY. Critical Care Medicine, 52(1), S722–S722. https://doi.org/10.1097/01.ccm.0001004168.21381.84

Zhalbinova, M. R., Rakhimova, S. E., Kozhamkulov, U. A., Akilzhanova, G. A., Chinybayeva, A. A., Akilzhanov, K. R., Shaimardanov, N. K., Kuanysheva, A. G., Lee, J. H., Kairov, U. Y., Bekbossynova, M. S., & Akilzhanova, A. R. (2023). Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3. Journal of Clinical Medicine, 12(23), 7235. https://doi.org/10.3390/jcm12237235

Adhikari, S., Mukhyopadhyay, A., Kolzoff, S., Li, X., Nadel, T., Fitchett, C., Chunara, R., Dodson, J., Kronish, I., & Blecker, S. B. (2023). Cohort profile: a large EHR-based cohort with linked pharmacy refill and neighbourhood social determinants of health data to assess heart failure medication adherence. BMJ Open, 13(12), e076812. https://doi.org/10.1136/bmjopen-2023-076812

Gue, Y., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (2023). Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. The American Journal of Medicine, 136(11), 1099-1108.e2. https://doi.org/10.1016/j.amjmed.2023.07.019

CHUZI, S., TONG, W., & NAKAGAWA, S. (2023). Towards Improved Patient-Centered Communication in High-Stakes Heart Failure Decisions: the “Best Case/Worst Case” Framework. Journal of Cardiac Failure, 29(11), 1561–1563. https://doi.org/10.1016/j.cardfail.2023.06.010

Corica, B., Romiti, G. F., Simoni, A. H., Mei, D. A., Thompson, J. L. P., Homma, S., Proietti, M., & Lip, G. Y. H. (2023). Educational level and risk of all-cause death in patients with heart failure with reduced ejection fraction (HFrEF): a report from the WARCEF Trial. European Heart Journal, 44(Supplement_2). https://doi.org/10.1093/eurheartj/ehad655.853

Cochran, J. D., Yura, Y., Thel, M. C., Doviak, H., Polizio, A. H., Arai, Y., Arai, Y., Horitani, K., Park, E., Chavkin, N. W., Kour, A., Sano, S., Mahajan, N., Evans, M., Huba, M., Naya, N. M., Sun, H., Ban, Y. H., Hirschi, K. K., … Walsh, K. (2023). Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction. Circulation, 148(15), 1165–1178. https://doi.org/10.1161/circulationaha.123.064170

Sekerak, R., Lerner, J. B.-A., Prasad, P., & Prasad, M. (2023). Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 90(10), 607–609. https://doi.org/10.3949/ccjm.90a.23004

Woo, J. L., Nash, K. A., Dragan, K., Crook, S., Neidell, M., Cook, S., Hannan, E. L., Jacobs, M., Goldstone, A. B., Petit, C. J., Vincent, R., Walsh-Spoonhower, K., Mosca, R., Kumar, T. K. S., Devejian, N., Kamenir, S. A., Alfieris, G. M., Swartz, M. F., Meyer, D., … Anderson, B. R. (2023). Chronic Medication Burden After Cardiac Surgery for Pediatric Medicaid Beneficiaries. Journal of the American College of Cardiology, 82(13), 1331–1340. https://doi.org/10.1016/j.jacc.2023.06.046

Okwuosa, I. S., Anderson, A., Petty, M., Wu, T., Andrei, A.-C., Kao, A., Spertus, J. A., Pham, D. T., Yancy, C. W., Dew, M. A., Hsich, E., Cotts, W., Hartupee, J., Pamboukian, S., Pagani, F., Lampert, B., Johnson, M., Murray, M., Tekeda, K., … Grady, K. L. (2023). Caregiver burden before heart transplantation and long-term mechanical circulatory support: Findings from the sustaining quality of life of the aged: Transplant or mechanical support (SUSTAIN-IT) study. The Journal of Heart and Lung Transplantation, 42(9), 1197–1204. https://doi.org/10.1016/j.healun.2023.01.015

Stephens, A. F., Šeman, M., Diehl, A., Pilcher, D., Barbaro, R. P., Brodie, D., Pellegrino, V., Kaye, D. M., Gregory, S. D., & Hodgson, C. (2023). ECMO PAL: using deep neural networks for survival prediction in venoarterial extracorporeal membrane oxygenation. Intensive Care Medicine, 49(9), 1090–1099. https://doi.org/10.1007/s00134-023-07157-x

Šeman, M., Stephens, A., Diehl, A., Pilcher, D., Barbaro, R., Brodie, D., Pellegrino, V., Kaye, D., Gregory, S., & Hodgson, C. (2023). ECMO PAL: Survival Prediction in Venoarterial Extracorporeal Membrane Oxygenation using Deep Neural Networks. Heart, Lung and Circulation, 32, S112–S113. https://doi.org/10.1016/j.hlc.2023.06.730

Cox, Z. L., Zalawadiya, S. K., Simonato, M., Redfors, B., Zhou, Z., Kotinkaduwa, L., Zile, M. R., Udelson, J. E., Lim, D. S., Grayburn, P. A., Mack, M. J., Abraham, W. T., Stone, G. W., & Lindenfeld, J. (2023). Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation. JACC: Heart Failure, 11(7), 791–805. https://doi.org/10.1016/j.jchf.2023.03.009

Park, E., Daniel, L., Dickson, A., Corriere, M., Nepal, P., Hall, K., Plummer, D., Dupont, W., Murray, K., Stein, C. M., Ray, W., & Chung, C. (2023). POS0265 ASSOCIATION OF PREGABALIN VS GABAPENTIN WITH INCIDENT CONGESTIVE HEART FAILURE IN PATIENTS WITH NON-CANCER PAIN. Scientific Abstracts. https://doi.org/10.1136/annrheumdis-2023-eular.2795

Cohen, L. P., Isaza, N., Hernandez, I., Lewis, G. D., Ho, J. E., Fonarow, G. C., Kazi, D. S., & Bellows, B. K. (2023). Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction. JAMA Cardiology, 8(5), 419. https://doi.org/10.1001/jamacardio.2023.0077

Valente, C. J., Chiuzan, C., Alreshq, R., Blot, T., Fine, D., Helmke, S., Rodriguez, C., Sabogal, N., Teruya, S., Winburn, M., Kurian, D., Raiszadeh, F., Maurer, M. S., & Ruberg, F. L. (2023). Physical Performance in Black and Hispanic Outpatients With Heart Failure: The SCAN-MP Study. CJC Open, 5(4), 292–302. https://doi.org/10.1016/j.cjco.2022.12.011

Edmiston, J. B., Cohn, E. G., Teruya, S. L., Sabogal, N., Massillon, D., Muralidhar, V., Rodriguez, C., Helmke, S., Fine, D., Winburn, M., Chiuzan, C., Hod, E. A., Raiszadeh, F., Kurian, D., Maurer, M. S., & Ruberg, F. L. (2023). Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study. PLOS ONE, 18(3), e0283730. https://doi.org/10.1371/journal.pone.0283730

Rieger, E. Y., Anderson, I. J., Press, V. G., Cui, M. X., Arora, V. M., Williams, B. C., & Tang, J. W. (2023). Implementation of a Biopsychosocial History and Physical Exam Template in the Electronic Health Record: Mixed Methods Study. JMIR Medical Education, 9, e42364. https://doi.org/10.2196/42364

Johansen, N. D., Vaduganathan, M., Zahir, D., Fiuzat, M., DeFilippis, E. M., Januzzi, J. L., Butler, J., O’Connor, C. M., Abraham, W. T., Psotka, M. A., McMurray, J. J. V., Dewan, P., Claggett, B. L., Solomon, S. D., Modin, D., Butt, J. H., Jensen, J. U. S., Schou, M., Torp-Pedersen, C., … Biering-Sørensen, T. (2023). A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study. Circulation: Heart Failure, 16(2). https://doi.org/10.1161/circheartfailure.122.009729

Mukhopadhyay, A., Adhikari, S., Li, X., Dodson, J. A., Kronish, I. M., Shah, B., Ramatowski, M., Chunara, R., Kozloff, S., & Blecker, S. (2022). Association Between Copayment Amount and Filling of Medications for Angiotensin Receptor Neprilysin Inhibitors in Patients With Heart Failure. Journal of the American Heart Association, 11(24). https://doi.org/10.1161/jaha.122.027662

Scotti, A., Coisne, A., Granada, J., Asch, F., Driggin, E., Zhou, Z., Kar, S., Lim, S., Cohen, D., Lindenfeld, J., Abraham, W., Mack, M., & Stone, G. (2022). TCT-338 Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. Journal of the American College of Cardiology, 80(12), B136–B137. https://doi.org/10.1016/j.jacc.2022.08.397

Genereux, P., Sharma, R., Cubeddu, R., Leon, M., Cohen, D., Kapadia, S., Makkar, R., Thourani, V., Dobbles, M., Barnhart, G., & Gillam, L. (2022). TCT-404 Prognostic Impact of Cardiac Damage Across the Spectrum of Aortic Stenosis Severity: Results From a Large Real-World Database. Journal of the American College of Cardiology, 80(12), B163–B164. https://doi.org/10.1016/j.jacc.2022.08.474

Crutchfield, C. R., Zhong, J. R., Lee, N. J., Fortney, T. A., Ahmad, C. S., & Lynch, T. S. (2022). Operative Time Less Than 1.5 Hours, Male Sex, Dependent Functional Status, Presence of Dyspnea, and Reoperations Within 30 days Are Independent Risk Factors for Readmission After ACLR. Arthroscopy, Sports Medicine, and Rehabilitation, 4(4), e1305–e1313. https://doi.org/10.1016/j.asmr.2022.04.010

Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, T., Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, L., Fiuzat, M., & McMurray, J. J. V. (2022). Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score. JACC: Heart Failure, 10(8), 543–555. https://doi.org/10.1016/j.jchf.2022.03.009

Kalil, R., Choi, D. Y., Geleris, J. D., Lee, J. I., & Wagner, M. P. (2022). Using clinical decision support tools to increase defibrillator deactivations in dying patients. BMJ Open Quality, 11(3), e001729. https://doi.org/10.1136/bmjoq-2021-001729

Lotan, D., Oren, D., Bae, D., Mulcahy, S., Atanda, A., DeFilippis, E., Fried, J., Raikhelkar, J., Clerkin, K., Topkara, V., Lin, E., Colombo, P., Sayer, G., Yuzefpolskaya, M., Lyons, J., & Uriel, N. (2022). Shared Care Program for Left Ventricular Assist Device (LVAD) Patients: Clinical Experience and Interim Report. The Journal of Heart and Lung Transplantation, 41(4), S357. https://doi.org/10.1016/j.healun.2022.01.1452

DeFilippis, E. M., Beale, A., Martyn, T., Agarwal, A., Elkayam, U., Lam, C. S. P., & Hsich, E. (2022). Heart Failure Subtypes and Cardiomyopathies in Women. Circulation Research, 130(4), 436–454. https://doi.org/10.1161/circresaha.121.319900

Sweitzer, N. K., Burkhoff, D., Airhart, S., & Fang, J. C. (2022). Grace Under Pressure. Circulation: Heart Failure, 15(2). https://doi.org/10.1161/circheartfailure.122.009513

Banker, S. L., Lakhaney, D., Hooe, B. S., McCann, T. A., Kostacos, C., & Lane, M. (2022). A Quality Improvement Approach to Improving Discharge Documentation. Pediatric Quality & Safety, 7(1), e428. https://doi.org/10.1097/pq9.0000000000000428